Meiji Seika and Dong-A pharmaceuticals will form a JV to develop and commercialize biosimilars, including DA-3111.

Meiji Seika Pharma Co. Ltd.

Japan / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Dong-A Pharmaceutical Co. Ltd.

South Korea / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced